nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—Colchicine—gout	0.33	0.548	CbGbCtD
Amphetamine—SLC22A5—Probenecid—gout	0.183	0.305	CbGbCtD
Amphetamine—CYP2A6—Prednisolone—gout	0.0883	0.147	CbGbCtD
Amphetamine—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.0155	0.0937	CbGpPWpGaD
Amphetamine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.0155	0.0934	CbGpPWpGaD
Amphetamine—SLC22A3—Abacavir transmembrane transport—ABCG2—gout	0.0124	0.0745	CbGpPWpGaD
Amphetamine—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.0118	0.071	CbGpPWpGaD
Amphetamine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.0117	0.0708	CbGpPWpGaD
Amphetamine—SLC22A3—Abacavir transport and metabolism—ABCG2—gout	0.00709	0.0428	CbGpPWpGaD
Amphetamine—Aspartame—SLC22A11—gout	0.00505	1	CrCbGaD
Amphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.0036	0.0217	CbGpPWpGaD
Amphetamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.00311	0.0188	CbGpPWpGaD
Amphetamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.0031	0.0187	CbGpPWpGaD
Amphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00273	0.0165	CbGpPWpGaD
Amphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00254	0.0153	CbGpPWpGaD
Amphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.00242	0.0146	CbGpPWpGaD
Amphetamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00236	0.0142	CbGpPWpGaD
Amphetamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00235	0.0142	CbGpPWpGaD
Amphetamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00219	0.0132	CbGpPWpGaD
Amphetamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00219	0.0132	CbGpPWpGaD
Amphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.00215	0.0129	CbGpPWpGaD
Amphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00184	0.0111	CbGpPWpGaD
Amphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00171	0.0103	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A11—gout	0.00164	0.00986	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC17A1—gout	0.00164	0.00986	CbGpPWpGaD
Amphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00163	0.00981	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—ABCG2—gout	0.00157	0.00948	CbGpPWpGaD
Amphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00151	0.00912	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—SLC2A9—gout	0.00143	0.00863	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC17A1—gout	0.00141	0.00853	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC22A11—gout	0.00141	0.00853	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC22A11—gout	0.00141	0.0085	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC17A1—gout	0.00141	0.0085	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A12—gout	0.00124	0.00748	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—SLC2A9—gout	0.00123	0.00742	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A9—gout	0.00115	0.00695	CbGpPWpGaD
Amphetamine—Photosensitivity reaction—Naproxen—gout	0.00111	0.00489	CcSEcCtD
Amphetamine—Weight decreased—Naproxen—gout	0.0011	0.00484	CcSEcCtD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC17A1—gout	0.0011	0.00664	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A11—gout	0.0011	0.00664	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—SLC2A9—gout	0.00109	0.00657	CbGpPWpGaD
Amphetamine—Depression—Naproxen—gout	0.00108	0.00476	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Naproxen—gout	0.00108	0.00473	CcSEcCtD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC22A12—gout	0.00107	0.00647	CbGpPWpGaD
Amphetamine—Acute coronary syndrome—Naproxen—gout	0.00107	0.00471	CcSEcCtD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—gout	0.00107	0.00644	CbGpPWpGaD
Amphetamine—Myocardial infarction—Naproxen—gout	0.00106	0.00468	CcSEcCtD
Amphetamine—Erythema multiforme—Allopurinol—gout	0.00106	0.00464	CcSEcCtD
Amphetamine—Urinary tract infection—Naproxen—gout	0.00106	0.00464	CcSEcCtD
Amphetamine—Tension—Indomethacin—gout	0.00105	0.00462	CcSEcCtD
Amphetamine—Sweating—Naproxen—gout	0.00104	0.00458	CcSEcCtD
Amphetamine—Nervousness—Indomethacin—gout	0.00104	0.00457	CcSEcCtD
Amphetamine—Angioedema—Colchicine—gout	0.00103	0.00453	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC17A3—gout	0.00102	0.00615	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC2A9—gout	0.000997	0.00601	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—gout	0.000993	0.00599	CbGpPWpGaD
Amphetamine—Angioedema—Indomethacin—gout	0.000978	0.0043	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC17A1—gout	0.000975	0.00588	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A11—gout	0.000975	0.00588	CbGpPWpGaD
Amphetamine—TAAR1—G alpha (s) signalling events—POMC—gout	0.000962	0.0058	CbGpPWpGaD
Amphetamine—Palpitations—Indomethacin—gout	0.000946	0.00416	CcSEcCtD
Amphetamine—Convulsion—Indomethacin—gout	0.000928	0.00408	CcSEcCtD
Amphetamine—Hypertension—Indomethacin—gout	0.000924	0.00407	CcSEcCtD
Amphetamine—Erythema multiforme—Naproxen—gout	0.000921	0.00405	CcSEcCtD
Amphetamine—Chest pain—Indomethacin—gout	0.000912	0.00401	CcSEcCtD
Amphetamine—CYP2A6—NRF2 pathway—SLC2A9—gout	0.000911	0.00549	CbGpPWpGaD
Amphetamine—Tremor—Allopurinol—gout	0.00091	0.004	CcSEcCtD
Amphetamine—Anxiety—Indomethacin—gout	0.000908	0.004	CcSEcCtD
Amphetamine—Agitation—Allopurinol—gout	0.000893	0.00393	CcSEcCtD
Amphetamine—Angioedema—Allopurinol—gout	0.000888	0.0039	CcSEcCtD
Amphetamine—Euphoric mood—Prednisolone—gout	0.000885	0.00389	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC17A3—gout	0.000882	0.00532	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC17A3—gout	0.000879	0.0053	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Indomethacin—gout	0.000874	0.00384	CcSEcCtD
Amphetamine—Euphoric mood—Hydrocortisone—gout	0.000865	0.0038	CcSEcCtD
Amphetamine—Tachycardia—Indomethacin—gout	0.000853	0.00375	CcSEcCtD
Amphetamine—Hyperhidrosis—Indomethacin—gout	0.000845	0.00372	CcSEcCtD
Amphetamine—Convulsion—Allopurinol—gout	0.000842	0.0037	CcSEcCtD
Amphetamine—Hypertension—Allopurinol—gout	0.000839	0.00369	CcSEcCtD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—gout	0.000834	0.00503	CbGpPWpGaD
Amphetamine—Anorexia—Indomethacin—gout	0.000833	0.00366	CcSEcCtD
Amphetamine—Tension—Naproxen—gout	0.000832	0.00366	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC17A1—gout	0.000831	0.00501	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A11—gout	0.000831	0.00501	CbGpPWpGaD
Amphetamine—Viral infection—Prednisone—gout	0.000829	0.00365	CcSEcCtD
Amphetamine—Nervousness—Naproxen—gout	0.000824	0.00362	CcSEcCtD
Amphetamine—Injury—Prednisolone—gout	0.000814	0.00358	CcSEcCtD
Amphetamine—Euphoric mood—Methylprednisolone—gout	0.000812	0.00357	CcSEcCtD
Amphetamine—Decreased appetite—Colchicine—gout	0.000799	0.00352	CcSEcCtD
Amphetamine—Injury—Hydrocortisone—gout	0.000795	0.0035	CcSEcCtD
Amphetamine—Tremor—Naproxen—gout	0.000795	0.0035	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Colchicine—gout	0.000794	0.00349	CcSEcCtD
Amphetamine—Anaphylactic shock—Allopurinol—gout	0.000793	0.00349	CcSEcCtD
Amphetamine—Fatigue—Colchicine—gout	0.000793	0.00349	CcSEcCtD
Amphetamine—Insomnia—Indomethacin—gout	0.00079	0.00348	CcSEcCtD
Amphetamine—Infection—Allopurinol—gout	0.000788	0.00346	CcSEcCtD
Amphetamine—Dyspnoea—Indomethacin—gout	0.000779	0.00343	CcSEcCtD
Amphetamine—Somnolence—Indomethacin—gout	0.000777	0.00342	CcSEcCtD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—gout	0.000775	0.00468	CbGpPWpGaD
Amphetamine—Angioedema—Naproxen—gout	0.000775	0.00341	CcSEcCtD
Amphetamine—Dyspepsia—Indomethacin—gout	0.000769	0.00338	CcSEcCtD
Amphetamine—Hyperhidrosis—Allopurinol—gout	0.000767	0.00337	CcSEcCtD
Amphetamine—Decreased appetite—Indomethacin—gout	0.00076	0.00334	CcSEcCtD
Amphetamine—Anorexia—Allopurinol—gout	0.000756	0.00332	CcSEcCtD
Amphetamine—Fatigue—Indomethacin—gout	0.000753	0.00331	CcSEcCtD
Amphetamine—Gastrointestinal pain—Colchicine—gout	0.000752	0.00331	CcSEcCtD
Amphetamine—Palpitations—Naproxen—gout	0.00075	0.0033	CcSEcCtD
Amphetamine—Constipation—Indomethacin—gout	0.000747	0.00329	CcSEcCtD
Amphetamine—Injury—Methylprednisolone—gout	0.000747	0.00328	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—gout	0.000739	0.00446	CbGpPWpGaD
Amphetamine—Affect lability—Prednisolone—gout	0.000736	0.00324	CcSEcCtD
Amphetamine—Convulsion—Naproxen—gout	0.000735	0.00323	CcSEcCtD
Amphetamine—Hypertension—Naproxen—gout	0.000732	0.00322	CcSEcCtD
Amphetamine—Urticaria—Colchicine—gout	0.000731	0.00321	CcSEcCtD
Amphetamine—Abdominal pain—Colchicine—gout	0.000727	0.0032	CcSEcCtD
Amphetamine—Chest pain—Naproxen—gout	0.000722	0.00318	CcSEcCtD
Amphetamine—Anxiety—Naproxen—gout	0.00072	0.00317	CcSEcCtD
Amphetamine—Affect lability—Hydrocortisone—gout	0.000719	0.00316	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC22A11—gout	0.000719	0.00434	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC17A1—gout	0.000719	0.00434	CbGpPWpGaD
Amphetamine—Insomnia—Allopurinol—gout	0.000717	0.00315	CcSEcCtD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC17A1—gout	0.000716	0.00432	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC22A11—gout	0.000716	0.00432	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Indomethacin—gout	0.000715	0.00314	CcSEcCtD
Amphetamine—Psychotic disorder—Hydrocortisone—gout	0.000713	0.00314	CcSEcCtD
Amphetamine—Mood swings—Prednisolone—gout	0.000709	0.00312	CcSEcCtD
Amphetamine—Dry mouth—Naproxen—gout	0.000706	0.00311	CcSEcCtD
Amphetamine—Somnolence—Allopurinol—gout	0.000705	0.0031	CcSEcCtD
Amphetamine—Dyspepsia—Allopurinol—gout	0.000698	0.00307	CcSEcCtD
Amphetamine—Irritability—Hydrocortisone—gout	0.000697	0.00307	CcSEcCtD
Amphetamine—MAOB—Phase 1 - Functionalization of compounds—POMC—gout	0.000694	0.00419	CbGpPWpGaD
Amphetamine—Urticaria—Indomethacin—gout	0.000694	0.00305	CcSEcCtD
Amphetamine—Anaphylactic shock—Naproxen—gout	0.000692	0.00305	CcSEcCtD
Amphetamine—Mood swings—Hydrocortisone—gout	0.000692	0.00304	CcSEcCtD
Amphetamine—Abdominal pain—Indomethacin—gout	0.000691	0.00304	CcSEcCtD
Amphetamine—Body temperature increased—Indomethacin—gout	0.000691	0.00304	CcSEcCtD
Amphetamine—Decreased appetite—Allopurinol—gout	0.000689	0.00303	CcSEcCtD
Amphetamine—Infection—Naproxen—gout	0.000688	0.00303	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—gout	0.000687	0.00414	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC17A3—gout	0.000686	0.00414	CbGpPWpGaD
Amphetamine—Gastrointestinal disorder—Allopurinol—gout	0.000685	0.00301	CcSEcCtD
Amphetamine—Constipation—Allopurinol—gout	0.000678	0.00298	CcSEcCtD
Amphetamine—Hypersensitivity—Colchicine—gout	0.000678	0.00298	CcSEcCtD
Amphetamine—Tachycardia—Naproxen—gout	0.000676	0.00297	CcSEcCtD
Amphetamine—Affect lability—Methylprednisolone—gout	0.000676	0.00297	CcSEcCtD
Amphetamine—Psychotic disorder—Methylprednisolone—gout	0.00067	0.00295	CcSEcCtD
Amphetamine—Hyperhidrosis—Naproxen—gout	0.000669	0.00294	CcSEcCtD
Amphetamine—Abdominal pain upper—Hydrocortisone—gout	0.000667	0.00293	CcSEcCtD
Amphetamine—Anorexia—Naproxen—gout	0.00066	0.0029	CcSEcCtD
Amphetamine—Asthenia—Colchicine—gout	0.00066	0.0029	CcSEcCtD
Amphetamine—Irritability—Methylprednisolone—gout	0.000655	0.00288	CcSEcCtD
Amphetamine—Mood swings—Methylprednisolone—gout	0.00065	0.00286	CcSEcCtD
Amphetamine—Gastrointestinal pain—Allopurinol—gout	0.000648	0.00285	CcSEcCtD
Amphetamine—Hypersensitivity—Indomethacin—gout	0.000644	0.00283	CcSEcCtD
Amphetamine—Euphoric mood—Prednisone—gout	0.000643	0.00283	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A12—gout	0.00063	0.0038	CbGpPWpGaD
Amphetamine—Urticaria—Allopurinol—gout	0.00063	0.00277	CcSEcCtD
Amphetamine—Diarrhoea—Colchicine—gout	0.000629	0.00277	CcSEcCtD
Amphetamine—Asthenia—Indomethacin—gout	0.000627	0.00276	CcSEcCtD
Amphetamine—Body temperature increased—Allopurinol—gout	0.000627	0.00276	CcSEcCtD
Amphetamine—Abdominal pain—Allopurinol—gout	0.000627	0.00276	CcSEcCtD
Amphetamine—Insomnia—Naproxen—gout	0.000626	0.00275	CcSEcCtD
Amphetamine—Dyspnoea—Naproxen—gout	0.000617	0.00271	CcSEcCtD
Amphetamine—Somnolence—Naproxen—gout	0.000615	0.00271	CcSEcCtD
Amphetamine—Dyspepsia—Naproxen—gout	0.000609	0.00268	CcSEcCtD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC17A3—gout	0.000608	0.00367	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—gout	0.000603	0.00364	CbGpPWpGaD
Amphetamine—Decreased appetite—Naproxen—gout	0.000602	0.00265	CcSEcCtD
Amphetamine—Diarrhoea—Indomethacin—gout	0.000598	0.00263	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Naproxen—gout	0.000598	0.00263	CcSEcCtD
Amphetamine—Fatigue—Naproxen—gout	0.000597	0.00263	CcSEcCtD
Amphetamine—Constipation—Naproxen—gout	0.000592	0.0026	CcSEcCtD
Amphetamine—Injury—Prednisone—gout	0.000591	0.0026	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC2A9—gout	0.000586	0.00353	CbGpPWpGaD
Amphetamine—Vomiting—Colchicine—gout	0.000585	0.00257	CcSEcCtD
Amphetamine—Hypersensitivity—Allopurinol—gout	0.000584	0.00257	CcSEcCtD
Amphetamine—Rash—Colchicine—gout	0.00058	0.00255	CcSEcCtD
Amphetamine—Dermatitis—Colchicine—gout	0.000579	0.00255	CcSEcCtD
Amphetamine—Dizziness—Indomethacin—gout	0.000578	0.00254	CcSEcCtD
Amphetamine—Headache—Colchicine—gout	0.000576	0.00253	CcSEcCtD
Amphetamine—Weight decreased—Hydrocortisone—gout	0.000571	0.00251	CcSEcCtD
Amphetamine—Asthenia—Allopurinol—gout	0.000569	0.0025	CcSEcCtD
Amphetamine—Acute coronary syndrome—Prednisolone—gout	0.000568	0.0025	CcSEcCtD
Amphetamine—Gastrointestinal pain—Naproxen—gout	0.000566	0.00249	CcSEcCtD
Amphetamine—Myocardial infarction—Prednisolone—gout	0.000565	0.00249	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A11—gout	0.000559	0.00337	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC17A1—gout	0.000559	0.00337	CbGpPWpGaD
Amphetamine—Vomiting—Indomethacin—gout	0.000556	0.00244	CcSEcCtD
Amphetamine—Acute coronary syndrome—Hydrocortisone—gout	0.000555	0.00244	CcSEcCtD
Amphetamine—Myocardial infarction—Hydrocortisone—gout	0.000552	0.00243	CcSEcCtD
Amphetamine—Rash—Indomethacin—gout	0.000551	0.00242	CcSEcCtD
Amphetamine—Dermatitis—Indomethacin—gout	0.00055	0.00242	CcSEcCtD
Amphetamine—Urticaria—Naproxen—gout	0.00055	0.00242	CcSEcCtD
Amphetamine—Headache—Indomethacin—gout	0.000547	0.00241	CcSEcCtD
Amphetamine—Body temperature increased—Naproxen—gout	0.000547	0.00241	CcSEcCtD
Amphetamine—Abdominal pain—Naproxen—gout	0.000547	0.00241	CcSEcCtD
Amphetamine—Nausea—Colchicine—gout	0.000546	0.0024	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC22A12—gout	0.000545	0.00329	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC22A12—gout	0.000543	0.00327	CbGpPWpGaD
Amphetamine—Diarrhoea—Allopurinol—gout	0.000543	0.00239	CcSEcCtD
Amphetamine—Affect lability—Prednisone—gout	0.000535	0.00235	CcSEcCtD
Amphetamine—Psychotic disorder—Prednisone—gout	0.000531	0.00233	CcSEcCtD
Amphetamine—Dizziness—Allopurinol—gout	0.000524	0.00231	CcSEcCtD
Amphetamine—Acute coronary syndrome—Methylprednisolone—gout	0.000521	0.00229	CcSEcCtD
Amphetamine—Nausea—Indomethacin—gout	0.000519	0.00228	CcSEcCtD
Amphetamine—Irritability—Prednisone—gout	0.000519	0.00228	CcSEcCtD
Amphetamine—Myocardial infarction—Methylprednisolone—gout	0.000518	0.00228	CcSEcCtD
Amphetamine—Mood swings—Prednisone—gout	0.000515	0.00226	CcSEcCtD
Amphetamine—Hypersensitivity—Naproxen—gout	0.00051	0.00224	CcSEcCtD
Amphetamine—Sweating—Methylprednisolone—gout	0.000507	0.00223	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC2A9—gout	0.000506	0.00305	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC2A9—gout	0.000505	0.00304	CbGpPWpGaD
Amphetamine—Vomiting—Allopurinol—gout	0.000504	0.00222	CcSEcCtD
Amphetamine—Rash—Allopurinol—gout	0.0005	0.0022	CcSEcCtD
Amphetamine—Dermatitis—Allopurinol—gout	0.000499	0.0022	CcSEcCtD
Amphetamine—Headache—Allopurinol—gout	0.000497	0.00218	CcSEcCtD
Amphetamine—Asthenia—Naproxen—gout	0.000497	0.00218	CcSEcCtD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A11—gout	0.000495	0.00299	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC17A1—gout	0.000495	0.00299	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—BCKDHA—gout	0.000488	0.00294	CbGpPWpGaD
Amphetamine—Diarrhoea—Naproxen—gout	0.000474	0.00208	CcSEcCtD
Amphetamine—Nausea—Allopurinol—gout	0.000471	0.00207	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000459	0.00277	CbGpPWpGaD
Amphetamine—Dizziness—Naproxen—gout	0.000458	0.00201	CcSEcCtD
Amphetamine—Vomiting—Naproxen—gout	0.00044	0.00194	CcSEcCtD
Amphetamine—Rash—Naproxen—gout	0.000436	0.00192	CcSEcCtD
Amphetamine—Dermatitis—Naproxen—gout	0.000436	0.00192	CcSEcCtD
Amphetamine—Headache—Naproxen—gout	0.000434	0.00191	CcSEcCtD
Amphetamine—Erectile dysfunction—Prednisone—gout	0.000433	0.0019	CcSEcCtD
Amphetamine—Weight decreased—Prednisone—gout	0.000425	0.00187	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—gout	0.000424	0.00256	CbGpPWpGaD
Amphetamine—Depression—Prednisone—gout	0.000418	0.00184	CcSEcCtD
Amphetamine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000417	0.00252	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—BCKDHA—gout	0.000413	0.00249	CbGpPWpGaD
Amphetamine—Acute coronary syndrome—Prednisone—gout	0.000413	0.00182	CcSEcCtD
Amphetamine—Angioedema—Prednisolone—gout	0.000412	0.00181	CcSEcCtD
Amphetamine—Nausea—Naproxen—gout	0.000411	0.00181	CcSEcCtD
Amphetamine—Myocardial infarction—Prednisone—gout	0.000411	0.00181	CcSEcCtD
Amphetamine—Angioedema—Hydrocortisone—gout	0.000402	0.00177	CcSEcCtD
Amphetamine—MAOB—Metabolism—PRPS2—gout	0.000398	0.0024	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PRPS1—gout	0.000398	0.0024	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HPRT1—gout	0.000398	0.0024	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—gout	0.000394	0.00238	CbGpPWpGaD
Amphetamine—Convulsion—Prednisolone—gout	0.00039	0.00172	CcSEcCtD
Amphetamine—Hypertension—Prednisolone—gout	0.000389	0.00171	CcSEcCtD
Amphetamine—Convulsion—Hydrocortisone—gout	0.000381	0.00168	CcSEcCtD
Amphetamine—Hypertension—Hydrocortisone—gout	0.00038	0.00167	CcSEcCtD
Amphetamine—Angioedema—Methylprednisolone—gout	0.000378	0.00166	CcSEcCtD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—gout	0.000376	0.00226	CbGpPWpGaD
Amphetamine—Anxiety—Hydrocortisone—gout	0.000373	0.00164	CcSEcCtD
Amphetamine—MAOB—Biological oxidations—POMC—gout	0.000369	0.00222	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Prednisolone—gout	0.000368	0.00162	CcSEcCtD
Amphetamine—Anaphylactic shock—Hydrocortisone—gout	0.000359	0.00158	CcSEcCtD
Amphetamine—Tachycardia—Prednisolone—gout	0.000359	0.00158	CcSEcCtD
Amphetamine—Convulsion—Methylprednisolone—gout	0.000358	0.00158	CcSEcCtD
Amphetamine—Hypertension—Methylprednisolone—gout	0.000357	0.00157	CcSEcCtD
Amphetamine—Infection—Hydrocortisone—gout	0.000357	0.00157	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisolone—gout	0.000355	0.00156	CcSEcCtD
Amphetamine—Anxiety—Methylprednisolone—gout	0.000351	0.00154	CcSEcCtD
Amphetamine—Tachycardia—Hydrocortisone—gout	0.00035	0.00154	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—POMC—gout	0.000349	0.00211	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—gout	0.000349	0.00211	CbGpPWpGaD
Amphetamine—Hyperhidrosis—Hydrocortisone—gout	0.000347	0.00153	CcSEcCtD
Amphetamine—Anorexia—Hydrocortisone—gout	0.000342	0.00151	CcSEcCtD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—gout	0.000338	0.00204	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Methylprednisolone—gout	0.000337	0.00148	CcSEcCtD
Amphetamine—SLC22A3—Metabolism—PRPS1—gout	0.000337	0.00203	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HPRT1—gout	0.000337	0.00203	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PRPS2—gout	0.000337	0.00203	CbGpPWpGaD
Amphetamine—Infection—Methylprednisolone—gout	0.000335	0.00147	CcSEcCtD
Amphetamine—Insomnia—Prednisolone—gout	0.000333	0.00146	CcSEcCtD
Amphetamine—Tachycardia—Methylprednisolone—gout	0.000329	0.00145	CcSEcCtD
Amphetamine—Hyperhidrosis—Methylprednisolone—gout	0.000326	0.00143	CcSEcCtD
Amphetamine—Insomnia—Hydrocortisone—gout	0.000325	0.00143	CcSEcCtD
Amphetamine—Dyspepsia—Hydrocortisone—gout	0.000316	0.00139	CcSEcCtD
Amphetamine—Decreased appetite—Hydrocortisone—gout	0.000312	0.00137	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Hydrocortisone—gout	0.00031	0.00136	CcSEcCtD
Amphetamine—Fatigue—Hydrocortisone—gout	0.00031	0.00136	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—gout	0.000308	0.00186	CbGpPWpGaD
Amphetamine—Insomnia—Methylprednisolone—gout	0.000305	0.00134	CcSEcCtD
Amphetamine—Agitation—Prednisone—gout	0.000301	0.00132	CcSEcCtD
Amphetamine—Angioedema—Prednisone—gout	0.000299	0.00132	CcSEcCtD
Amphetamine—Dyspepsia—Methylprednisolone—gout	0.000297	0.00131	CcSEcCtD
Amphetamine—Gastrointestinal pain—Hydrocortisone—gout	0.000294	0.00129	CcSEcCtD
Amphetamine—Urticaria—Prednisolone—gout	0.000292	0.00128	CcSEcCtD
Amphetamine—Fatigue—Methylprednisolone—gout	0.000291	0.00128	CcSEcCtD
Amphetamine—Urticaria—Hydrocortisone—gout	0.000285	0.00125	CcSEcCtD
Amphetamine—Abdominal pain—Hydrocortisone—gout	0.000284	0.00125	CcSEcCtD
Amphetamine—Body temperature increased—Hydrocortisone—gout	0.000284	0.00125	CcSEcCtD
Amphetamine—Convulsion—Prednisone—gout	0.000284	0.00125	CcSEcCtD
Amphetamine—Hypertension—Prednisone—gout	0.000283	0.00124	CcSEcCtD
Amphetamine—Anxiety—Prednisone—gout	0.000278	0.00122	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methylprednisolone—gout	0.000276	0.00121	CcSEcCtD
Amphetamine—Hypersensitivity—Prednisolone—gout	0.000271	0.00119	CcSEcCtD
Amphetamine—Urticaria—Methylprednisolone—gout	0.000268	0.00118	CcSEcCtD
Amphetamine—Anaphylactic shock—Prednisone—gout	0.000267	0.00118	CcSEcCtD
Amphetamine—Abdominal pain—Methylprednisolone—gout	0.000267	0.00117	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ABCG2—gout	0.000266	0.0016	CbGpPWpGaD
Amphetamine—Infection—Prednisone—gout	0.000265	0.00117	CcSEcCtD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ABCG2—gout	0.000265	0.0016	CbGpPWpGaD
Amphetamine—Hypersensitivity—Hydrocortisone—gout	0.000265	0.00116	CcSEcCtD
Amphetamine—Tachycardia—Prednisone—gout	0.000261	0.00115	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisone—gout	0.000258	0.00114	CcSEcCtD
Amphetamine—Asthenia—Hydrocortisone—gout	0.000258	0.00113	CcSEcCtD
Amphetamine—Anorexia—Prednisone—gout	0.000255	0.00112	CcSEcCtD
Amphetamine—Hypersensitivity—Methylprednisolone—gout	0.000249	0.00109	CcSEcCtD
Amphetamine—Diarrhoea—Hydrocortisone—gout	0.000246	0.00108	CcSEcCtD
Amphetamine—Dizziness—Prednisolone—gout	0.000243	0.00107	CcSEcCtD
Amphetamine—Asthenia—Methylprednisolone—gout	0.000242	0.00106	CcSEcCtD
Amphetamine—Insomnia—Prednisone—gout	0.000242	0.00106	CcSEcCtD
Amphetamine—CYP2A6—Metabolism—BCKDHA—gout	0.000238	0.00143	CbGpPWpGaD
Amphetamine—Dizziness—Hydrocortisone—gout	0.000237	0.00104	CcSEcCtD
Amphetamine—Dyspepsia—Prednisone—gout	0.000235	0.00103	CcSEcCtD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000234	0.00141	CbGpPWpGaD
Amphetamine—Decreased appetite—Prednisone—gout	0.000232	0.00102	CcSEcCtD
Amphetamine—Rash—Prednisolone—gout	0.000232	0.00102	CcSEcCtD
Amphetamine—Dermatitis—Prednisolone—gout	0.000232	0.00102	CcSEcCtD
Amphetamine—Diarrhoea—Methylprednisolone—gout	0.000231	0.00102	CcSEcCtD
Amphetamine—Fatigue—Prednisone—gout	0.00023	0.00101	CcSEcCtD
Amphetamine—Headache—Prednisolone—gout	0.00023	0.00101	CcSEcCtD
Amphetamine—Constipation—Prednisone—gout	0.000228	0.001	CcSEcCtD
Amphetamine—Vomiting—Hydrocortisone—gout	0.000228	0.001	CcSEcCtD
Amphetamine—Rash—Hydrocortisone—gout	0.000226	0.000996	CcSEcCtD
Amphetamine—Dermatitis—Hydrocortisone—gout	0.000226	0.000995	CcSEcCtD
Amphetamine—Headache—Hydrocortisone—gout	0.000225	0.000989	CcSEcCtD
Amphetamine—Dizziness—Methylprednisolone—gout	0.000223	0.000981	CcSEcCtD
Amphetamine—Gastrointestinal pain—Prednisone—gout	0.000218	0.000961	CcSEcCtD
Amphetamine—Nausea—Prednisolone—gout	0.000218	0.000961	CcSEcCtD
Amphetamine—Vomiting—Methylprednisolone—gout	0.000214	0.000943	CcSEcCtD
Amphetamine—Nausea—Hydrocortisone—gout	0.000213	0.000938	CcSEcCtD
Amphetamine—Rash—Methylprednisolone—gout	0.000213	0.000936	CcSEcCtD
Amphetamine—Dermatitis—Methylprednisolone—gout	0.000212	0.000935	CcSEcCtD
Amphetamine—Urticaria—Prednisone—gout	0.000212	0.000934	CcSEcCtD
Amphetamine—Headache—Methylprednisolone—gout	0.000211	0.00093	CcSEcCtD
Amphetamine—Abdominal pain—Prednisone—gout	0.000211	0.000929	CcSEcCtD
Amphetamine—Body temperature increased—Prednisone—gout	0.000211	0.000929	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCG2—gout	0.000207	0.00125	CbGpPWpGaD
Amphetamine—Nausea—Methylprednisolone—gout	0.0002	0.000881	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—gout	0.000197	0.00119	CbGpPWpGaD
Amphetamine—Hypersensitivity—Prednisone—gout	0.000197	0.000866	CcSEcCtD
Amphetamine—CYP2A6—Metabolism—PRPS2—gout	0.000194	0.00117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRPS1—gout	0.000194	0.00117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HPRT1—gout	0.000194	0.00117	CbGpPWpGaD
Amphetamine—Asthenia—Prednisone—gout	0.000192	0.000843	CcSEcCtD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	0.00019	0.00114	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCG2—gout	0.000183	0.00111	CbGpPWpGaD
Amphetamine—Diarrhoea—Prednisone—gout	0.000183	0.000804	CcSEcCtD
Amphetamine—CYP2A6—Biological oxidations—POMC—gout	0.00018	0.00108	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—gout	0.000179	0.00108	CbGpPWpGaD
Amphetamine—Dizziness—Prednisone—gout	0.000177	0.000777	CcSEcCtD
Amphetamine—Vomiting—Prednisone—gout	0.00017	0.000747	CcSEcCtD
Amphetamine—Rash—Prednisone—gout	0.000168	0.000741	CcSEcCtD
Amphetamine—Dermatitis—Prednisone—gout	0.000168	0.00074	CcSEcCtD
Amphetamine—Headache—Prednisone—gout	0.000167	0.000736	CcSEcCtD
Amphetamine—Nausea—Prednisone—gout	0.000159	0.000698	CcSEcCtD
Amphetamine—MAOB—Metabolism—ABCG2—gout	0.000147	0.000888	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—gout	0.000135	0.000811	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCKDHA—gout	0.000133	0.000804	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCG2—gout	0.000125	0.000751	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRPS2—gout	0.000109	0.000656	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRPS1—gout	0.000109	0.000656	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HPRT1—gout	0.000109	0.000656	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000107	0.000645	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—gout	0.000106	0.000639	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—gout	0.000101	0.000608	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—gout	8.15e-05	0.000491	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCG2—gout	7.17e-05	0.000433	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—gout	6.31e-05	0.00038	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—gout	5.34e-05	0.000322	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—gout	4.6e-05	0.000278	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—gout	4.18e-05	0.000252	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG2—gout	4.02e-05	0.000243	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—gout	3.07e-05	0.000185	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—gout	2.47e-05	0.000149	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—gout	1.72e-05	0.000104	CbGpPWpGaD
